Edition:
United Kingdom

Orion Oyj (ORNAV.HE)

ORNAV.HE on Helsinki Stock Exchange

31.81EUR
14 Dec 2017
Change (% chg)

€-0.48 (-1.49%)
Prev Close
€32.29
Open
€32.29
Day's High
€32.30
Day's Low
€31.81
Volume
12,379
Avg. Vol
10,373
52-wk High
€58.35
52-wk Low
€31.38

Summary

Name Age Since Current Position

Heikki Westerlund

51 2017 Independent Chairman of the Board

Timo Lappalainen

55 2008 President, Chief Executive Officer, Chairman of the Executive Management Board

Timo Maasilta

63 2016 Independent Vice Chairman of the Board

Jari Karlson

56 2010 Chief Financial Officer, Senior Vice President, Animal Health, Member of the Executive Management Board

Satu Ahomaki

51 2010 Senior Vice President, Global Sales; Member of the Executive Management Board

Markku Huhta-Koivisto

61 2014 Senior Vice President, Proprietary Products; Member of the Executive Management Board

Liisa Hurme

50 2014 Senior Vice President, Specialty Products and Chairman of the Board of Fermion Oy; Member of the Executive Management Board

Virve Laitinen

45 2012 Senior Vice President, Supply Chain; Member of the Executive Management Board

Christer Nordstedt

55 2017 Senior Vice President for Research and Development, Member of the Executive Management Board

Olli Huotari

51 2006 Senior Vice President, Corporate Functions; Member of the Executive Management Board; Secretary

Marko Torppala

2015 Employee Representative on the Executive Management Board

Sirpa Jalkanen

63 2009 Independent Director

Ari Lehtoranta

54 2017 Independent Director

Hilpi Rautelin

2017 Independent Director

Eija Ronkainen

51 2016 Independent Director

Mikael Silvennoinen

61 2014 Independent Director

Biographies

Name Description

Heikki Westerlund

Mr. Heikki Westerlund has served as Independent Chairman of the Board of Directors of Orion Oyj since March 22, 2017. He has been Independent Member of the Board of Directors of the Company since March 24, 2010. He is also Chairman of the Company's Remuneration Committee and Member of the Research & Development Committee. Mr. Westerlund was Chairman of the Board of Directors of CapMan Plc (2010-2013) and has been its Chief Executive Officer since 2013. He previously worked for Capman and held such positions as Chief Executive Officer (2005-2010), Head of CapMan Buyout team (2002-2005), Head of Technology team (2000-2002), Investment Director (1997-2001), and Investment Manager (1994-1997). He was also Investment Analyst and Project Manager at Finnish Fund for Research and Development SITRA (1990-1994) and Managing Director of Foresport Oy (1988-1989). He has been Chairman of the Board of Norvestia Oyj since 2015 and Member of the Board of Walki Oy since 2011. He was previously Member or Chairman of the Board of Directors of Aldata Solution Oyj (1997-2001), AtBusiness Communications Oyj (1997-2003), Finnish Venture Capital Association (2007-2011), Lumene Ltd (2006-2013), Medianorth Group Oy (1999-2004), Nexor Superstore (1995-1998) and Satama Interactive (1997-2000). He holds Master of Science degree in Economics.

Timo Lappalainen

Mr. Timo Lappalainen has served as President, Chief Executive Officer and Chairman of the Executive Management Board of Orion Oyj since January 1, 2008. He joined Orion in 1999 as Senior Vice President, Business Development (1999-2003) and later on moved to the position of Executive Vice President, Orion Pharma (2003-2005). In 2005, he was appointed Senior Vice President, Proprietary Products and Animal Health, and held the position until 2007. Prior to joining Orion, he worked as Vice President, International Marketing and Business Development at Leiras Oy (1994-1999); Vice President, Business Development and General Manager of Finvest's German unit at Finvest Ltd. (1989-1993), and Consultant at Arthur Andersen & Co., Chicago, the United States (1987-1988). Mr. Lappalainen has been Vice Chairman of the Board of Directors of Chemical Industry Federation of Finland since 2017. He is also Member of the Board of Confederation of Finnish Industries, EK since 2015, Kemira Oyj since 2014, Chemical Industry Federation of Finland since 2008, Finnish Foundation for Cardiovascular Research since 2010, as well as Member of the Supervisory Board of The Finnish Fair Corporation since 2009. In addition, he is a member of the Council of the Helsinki Region Chamber of Commerce. He was Chairman of the Board of Chemical Industry Federation of Finland (2015-2016), Vice Chairman of the Board of Chemical Industry Federation of Finland (2013-2014), Member of the Board of Confederation of Finnish Industries, EK (2015-2016), Vaisala Oyj (2011-2014) and ICC Finland (2014). He holds Master of Science degree in Engineering.

Timo Maasilta

Mr. Timo Maasilta has served as Independent Vice Chairman of the Board of Orion Oyj since March 22, 2016. Before that, he has been Independent Director since March 20, 2012. He is Member of the Nomination Committee, Remuneration Committee and Research and Development Committee of the Company. He has been Managing Director of Maa- ja vesitekniikan tuki ry since 1993 and Tukinvest Oy since 1984. He served as Engineer at Vesi-Pekka Oy (1982-1984) and as Project Engineer at Vesi-Pekka Oy, Libya (1980-1982). He has been Chairman of the Boards of Maa- ja vesitekniikan tuki ry since 1998, Tuen Kiinteistot Oy since 1985, Ymparistoviestinta YVT Oy since 2001, as well as Member of the Board of Tukinvest Oy since 1996 and Vice Chairman of Amer Cultural Foundation since 2010. He also serves as Member of the advisory board of the Helsinki University Faculty of Agriculture and Forestry since 2015 and Editor-in-chief of the Vesitalous-magazine since 1998. He was previously Member of the Board of Directors of Amer Sports Corporation (1986-2008), Amer Cultural Foundation (1986-2009) and Ompus Inc. (1984-1994), Chairman of the Nomination Committee of Orion Corporation (2004-2011), Member of the Nomination Committee of Oriola-KD Corporation (2006-2007 and 2010-2011), Member of the Supervisory Board of Orion Corporation (1991-2002) and Amer Group (1985-1986). Mr. Timo Maasilta holds a Master of Science Degree in Engineering.

Jari Karlson

Mr. Jari Karlson has served as Chief Financial Officer and Member of the Executive Management Board of Orion Oyj since August 1, 2002. Since November 2010 he has also been Senior Vice President, Animal Health at the Company. He joined the Company in 2001 as Vice President, Finance of Orion Pharma. Prior to that, he was Vice President, Finance of Kuusakoski Group Oy (1999-2001) and Controller, Director of Planning for the Europe and Asia region and Director of Finance in Europe at Genencor International Inc. (1990-1999), and Financial Controller for the Biochem division of Cultor Oy (1988-1989). Mr. Karlson has been Member of the Board of Elo Mutual Pension Insurance Company since 2010, of the Finnish Foundation of Veterinary Research since 2011 and of Polttimo Oy since 2012. He holds Master of Science degree in Economics.

Satu Ahomaki

Ms. Satu Ahomaki has served as Senior Vice President, Global Sales at Orion Oyj since October 1, 2010. She has also been Member of the Executive Management Board of the Company since January 1, 2008. She is also Member of European Federation of Pharmaceutical Industries and Associations (EFPIA) and European Markets Committee since 2015. She was Senior Vice President, Animal Health in the Company from January 1, 2008 to October 1, 2010. She joined Orion in 1992 and held such positions as Head of Business Development (2006-2007), Business Development Director (2005) and Project Manager and Program Leader of hormonal and urological therapies (2000-2004). Between 1992 and 1999 she held several duties in pharmaceutical Research & Development. Before joining the Company, she worked in accounting in different companies. She holds Master of Science degree in Economics.

Markku Huhta-Koivisto

Mr. Markku Huhta-Koivisto has been Senior Vice President, Proprietary Products of Orion Oyj, since January 1, 2014. He has been Member of the Executive Management Board of the Company since November 1, 2006. He served as Senior Vice President, Specialty Products and Fermion in the Company from November 1, 2006 until 1, 2014. He joined the Company in 1982 as Production Planning Manager of Orion-Farmos Pharmaceuticals, where he later on held such positions as Plant Manager (1984-1987), Materials Manager (1987-1990) and Director and Vice President, Materials Management of Farmos Oy, Pharmaceutical Division (1990-1991). He was also Director, Materials Management at Orion-Farmos Pharmaceuticals (1991-1996), Director and Vice President, Materials Management at Orion Pharma (1996-1998), Vice President, International Sales at Orion Pharma (1998-2000), Program Director, business processes and information systems at Orion Pharma (2000-2002) and Senior Vice President, Supply Chain at Orion Pharma (2002-2004). After that, he moved to Fermion Oy, and served as its President (2004-2005). He was also Senior Vice President, Supply Chain at Orion Pahrma (2004-2006). Previously, he was Development Engineer at Oy Santasalo-Sohlberg Ab (1981-1982). Mr. Huhta-Koivisto was Member of the Board of Pharmaservice Oy (2011-2014) and Member of the Health Cluster of the National Emergency Supply Organization, NESO (2007-2014) and Member of the Chemical Industry Pool Committee of the National Emergency Supply Organization, NESO (2006-2007). He holds a Master of Science degree in Engineering and a Master of Business Administration degree.

Liisa Hurme

Dr. Liisa Hurme has been Senior Vice President, Specialty Products and Chairman of the Board of Fermion Oy at Orion Oyj since January 1, 2014. She has been Member of the Executive Management Board of the Company since January 1, 2008. She served as Senior Vice President, Proprietary Products at the Company form January 1, 2008 until January 1, 2014. She joined the Company in 1999 as Researcher and Project Manager, Hormonal therapies, and held the position until 2001. Later on, she moved to Project Manager position (2001-2002) and in 2002 was appointed Portfolio Manager. After two years, she became Program Leader of pharmaceutical development projects for Hormonal and Urological therapies (2004-2005) and was appointed Head of Urology and Oncology business in 2005. Prior to Orion, she worked for Pharmacia & Upjohn (1995-1999) as Researcher at Diagnostics Unit, Sweden, and as Researcher, Development projects at ELIAS GmbH, Germany, and Institute Pasteur, France. She was Member of the Board of Directors of Finnish Bioindustries FIB (2010-2016) and Pharmaservice Oy (2014-2016); Member of the Economic & Social Policy Committee of the European Federation of Pharmaceutical Industries and Associations EFPIA (2010-2015), as well as Member of the Healthcare Sector Committee of the National Emergency Supply Organization (NESO) (2014-2015). She holds Doctorate in Philosophy degree in Biochemistry from the University of Helsinki, Faculty of Science, 1996.

Virve Laitinen

Ms. Virve Laitinen has served as Senior Vice President, Supply Chain and Member of the Executive Management Board of Orion Oyj since January 1, 2012. She previously served in the Company as Director of Orion's Business Planning and Control as well as Finance (2007-2011), Supply Chain, Manager, Industrialization and Contract Manufacturing (2001-2006), and Supply Chain, Development Engineer (1997-2000). She is also Member of the Healthcare Sector Committee of the National Emergency Supply Organisation (NESO) since 2015. Ms. Virve Laitinen holds a Master of Science degree in Technology and Master of Business Administration degree.

Christer Nordstedt

Dr. Christer Nordstedt, M.D., Ph.D. has been appointed Senior Vice President for Research and Development and Member of the Executive Management Board at Orion Oyj effective as of February 21, 2017. Nordstedt joins Orion from Eli Lilly, USA, where his latest position was Vice President and Head CNS Research and Clinical Investigation. Nordstedt has worked at Eli Lilly since 2011. Before that time he worked for many years in various leadership positions in Research and Development at Roche in Switzerland and at AstraZeneca in Sweden. Prior to his career in the pharmaceutical industry, Nordstedt held the position of Laboratory Head at the Karolinska Institute in Stockholm, Sweden. Prior to that, Nordstedt worked in the laboratory of Dr. Paul Greengard (Nobel Laureate 2000) at the Rockefeller University in New York, USA.

Olli Huotari

Mr. Olli Huotari has served as Senior Vice President, Corporate Functions (Communications, Human Resources, Intellectual Property Rights and Legal Affairs) and Member of the Executive Management Board of Orion Oyj since June 1, 2006. He has also been holding the position of Secretary to the Board of Directors of the Company since October 1, 2002, and was General Counsel of the Company from October 1, 2002 to June 1, 2006. Mr. Huotari started his career in Orion in 1996. He joined the Company as Legal Counsel in Corporate Administration, and held the position until 2002. Later on, he was appointed General Counsel of the Orion Group (2002-2006) and after that, Vice President, Human Resources of Orion Pharma and Corporate Vice President, HR development of the Orion Group (2005-2006). Prior to joining the Company, he was Legal Counsel at Law firm Asianajotoimisto Jouko Penttila Oy (1992-1995). His current key positions of trust include Member of Finland Chamber of Commerce, Committee of International Trade since 2017, as well as Member of International Chamber of Commerce ICC Finland, ICC Advisory Board since 2016. Mr. Huotari obtained a Master of Laws degree in International Commercial Law from University of Kent at Canterbury, England in 1996.

Marko Torppala

Mr. Marko Torppala has served as Employee Representative on the Executive Management Board of Orion Oyj since January 1, 2015. He is Compression Machine Operator.

Sirpa Jalkanen

Ms. Sirpa Jalkanen has served as Independent Member of the Board of Directors of Orion Oyj since March 23, 2009. She is also Chairman of the Company's Research & Development Committee. She has been Academy professor since 2014. She was Vice Dean of the University of Turku (2010-2013), where she has also served as Professor of Immunology since 2001. In addition she has held a Director position at Centre of Excellence of the Finnish Academy (2008-2013, earlier 2000-2005) and has been Research Professor at National Institute for Health and Welfare since 2006. She was Academy professor from 1996 to 2006. She was also Researcher at University of Turku, Academy of Finland, THL (1986-1996) and at Stanford University in United States (1983-1986). She has served on the Board of Directors of Emil Aaltonen Foundation since 2000 and Tampere University of Technology since 2010, as well as Member of the committee of medical experts of Sigrid Juselius Foundation since 2001, and Member of the Scientific Committee of the Cancer Institute since 2002. In addition, she was Chairman of the Finnish Academy of Science and Letters (2010-2012). She has published about 250 scientific articles on mechanisms of inflammatory diseases and spreading of cancer. She has several related patents granted and pending. She is Professor and holds Medical Doctor degree.

Ari Lehtoranta

Mr. Ari Lehtoranta has served as Independent Member of the Board of Directors of Orion Oyj since March 22, 2017. He is also Member of the Company’s Audit Committee and Research and Development Committee.

Hilpi Rautelin

Prof. Hilpi Rautelin has served as Independent Member of the Board of Directors of Orion Oyj since March 22, 2017. She is also Member of the Company’s Audit Committee and Research and Development Committee.

Eija Ronkainen

Ms. Eija Ronkainen has held the position of Independent Member of the Board of Directors at Orion Oyj, since March 22, 2016. She is Member of the Company's Audit Committee and Research and Development Committee. Since 2015 she has been Member of the Board of Directors at EVK-Capital Oy. In 2006 she was Specialist in Internal Medicine, Hyvinkaa Hospital. From 1999 until 2002 she served as Specialist in Internal Medicine, Hyvinkaa Hospital. Between 1995 and 1999 she acted as Resident Physician, Helsinki University Central Hospital and between 1992 and 1995 she was Resident Physician at Hyvinkaa Hospital. Ms. Eija Ronkainen holds a Licentiate of Medicine. She is a Specialist in Internal Medicine.

Mikael Silvennoinen

Mr. Mikael Silvennoinen has been Independent Member of the Board of Directors of Orion Oyj since March 25, 2014. He is Chairman of the Audit Committee, and Member of the Remuneration Committee and the R&D Committee. He has been Executive Chairman of IMS Talent Oy since 2013. He was previously President and Chief Executive Officer (CEO,) Chairman of the Executive Committee of Pohjola Bank Plc from 1997 until 2013; Member of the Executive Board, Head of Capital markets, Pohjola Bank Plc (1997); Head of Investment banking and International affairs, Pohjola Bank Plc (1994-1997); Head of private equity, Pohjola Bank Plc (1989-1992); Group treasurer, Wartsila Corporation (1988-1989); Finance manager, Wartsila Corporation (1986-1988) and Dealer, Wartsila Corporation (1983-1985). He has also served as Member of the Board of Directors of Pontos Oy since 2014, Hartwall Capital Ltd. since 2014 and Metsaliitto Cooperative since 2015. Previously, he was Chairman of the Board of Directors of Pohjola Insurance Ltd (2005-2012), Pohjola Asset Management Ltd (2005-2012), Helsinki OP Retail Bank Plc (1997-2005) and Member of the Board of Directors of Pohjola Group Oyj (2000-2001) and Unico Banking Group (1997-2013). He holds a Master of Science degree in Economics.